CriticalTricyclic antidepressants (TCA)×First-generation antipsychotic, diphenylbutylpiperidine derivative
Updated · Methodology
Mechanism
Pimozide prolongs the QT interval, and ventricular arrhythmias, torsade de pointes and sudden death have been reported with it, including at usual doses (pimozide summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, and pimozide label, US Food and Drug Administration, FDA). QT prolongation and arrhythmias have also been reported with amitriptyline. Arrhythmias are likely at high doses and can occur at usual doses in people with heart disease (amitriptyline SmPC, AEMPS). The US pimozide label itself counts tricyclic antidepressants among QT-prolonging drugs and anticipates an additive effect on QT with pimozide (FDA pimozide label). According to the Spanish amitriptyline SmPC, tricyclic antidepressants and neuroleptics, a group that includes pimozide, also inhibit each other's metabolism, which may lower the seizure threshold (amitriptyline and pimozide SmPCs, AEMPS). The documents give no figures for this pair. The enzymes CYP3A4 and CYP2D6, and to a lesser extent CYP1A2, metabolise pimozide, while CYP2D6 and CYP2C19 are the main enzymes for amitriptyline (pimozide and amitriptyline SmPCs, AEMPS).
Symptoms
QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG). A ventricular arrhythmia causes palpitations, dizziness or fainting and can lead to cardiac arrest. With pimozide, QT prolongation, ventricular arrhythmias and torsade de pointes have been reported very rarely in people without risk factors. Ventricular tachycardia and ventricular fibrillation, sometimes fatal, cardiac arrest and sudden death have also been reported (pimozide summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). In amitriptyline overdose, the ECG shows QT prolongation and QRS widening, with ventricular tachyarrhythmias, torsade de pointes and ventricular fibrillation (amitriptyline SmPC, AEMPS). Together with neuroleptics, tricyclic antidepressants can cause a marked rise in body temperature, especially in hot weather (amitriptyline SmPC, AEMPS, and amitriptyline label, US Food and Drug Administration, FDA). The mutual inhibition of metabolism may lead to seizures (AEMPS). The risk of arrhythmia is higher with low potassium or magnesium and a slow heart rate (pimozide and amitriptyline SmPCs, AEMPS).
Management
The combination is contraindicated. The Spanish pimozide summary of product characteristics (SmPC) contraindicates pimozide with drugs known to prolong the QT interval and lists tricyclic antidepressants among them, naming amitriptyline (pimozide SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The US pimozide label also contraindicates pimozide with QT-prolonging drugs and itself counts tricyclic antidepressants among them. The Spanish amitriptyline SmPC, for its part, reports QT prolongation with amitriptyline (pimozide label, US Food and Drug Administration, FDA, and amitriptyline SmPC, AEMPS). The Spanish amitriptyline SmPC is less strict: it lists pimozide among QT-prolonging drugs under combinations that are not recommended, because together with tricyclic antidepressants they increase the likelihood of ventricular arrhythmias (amitriptyline SmPC, AEMPS). No document states how long to wait between stopping one drug and starting the other. The mean half-life of pimozide is about 55 hours, with more than tenfold differences in blood levels between people, and the half-life of amitriptyline is about 25 hours (pimozide and amitriptyline SmPCs, AEMPS). Pimozide is contraindicated in low potassium or magnesium and clinically significant bradycardia. Do an electrocardiogram (ECG) before starting pimozide and repeat it periodically, and stop pimozide if the QT or heart-rate-corrected QT (QTc) exceeds 500 ms (pimozide SmPC, AEMPS). Avoid diuretics with pimozide, especially those that lower potassium (pimozide SmPC, AEMPS). Use amitriptyline with caution in significant bradycardia, decompensated heart failure and with QT-prolonging drugs (amitriptyline SmPC, AEMPS). Together with neuroleptics, tricyclic antidepressants can cause a marked rise in body temperature, especially in hot weather (amitriptyline SmPC, AEMPS, and amitriptyline label, FDA). The mutual inhibition of metabolism may require dose adjustment (amitriptyline SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Pimozide tablets, USP (ANI Pharmaceuticals) – prescribing information (2026)– FDA label, ANI Pharmaceuticals, DailyMed setid 4e954fc2-fdff-486c-beb6-2b8ace717081, version 3, 07/2026, INDICATIONS AND USAGE, CONTRAINDICATIONS, PRECAUTIONS: Drug Interactions
- FDA: Amitriptyline hydrochloride tablets (amitriptyline) prescribing information (2026)– FDA label, Sun Pharmaceutical Industries, DailyMed setid 4e520c63-1cf6-40f6-a51c-3f9b0e181342, revised 09/2026, Contraindications, Warnings (Serotonin Syndrome) and PRECAUTIONS: Drug Interactions (Drugs Metabolized by P450 2D6)
- AEMPS: Ficha técnica: Amitriptilina, Tryptizol 25 mg (nº registro 37130), secciones 4.4 y 4.5 (2025)– AEMPS, CIMA, nº registro 37130, revisión 01/2025, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Orap (pimozida) (nº registro 49503), secciones 4.3 y 4.5 (2026)– AEMPS, CIMA, nº registro 49503, revisión 10/2026, secciones 4.3, 4.4 y 4.5